Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Myelogenous Leukemia in Chronic Phase”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00111683
What this trial is testing

MK0457 in Patients With Leukemia (0457-003)

Who this might be right for
Chronic Myelogenous Leukemia in Blast CrisisLymphocytic Leukemia, B Cell, AcuteMyelodysplastic Syndromes+1 more
Merck Sharp & Dohme LLC 28
Early research (Phase 1)Active Not RecruitingNCT02091245
What this trial is testing

Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML

Who this might be right for
Relapsed Acute Lymphoblastic Leukemia (ALL)Refractory Acute Lymphoblastic Leukemia (ALL)Relapsed Acute Myelogenous Leukemia (AML)+6 more
Dana-Farber Cancer Institute 16
Not applicableStudy completedNCT00993694
What this trial is testing

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
Vanderbilt University 41
Testing effectiveness (Phase 2)Looking for participantsNCT03934372
What this trial is testing

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaAccelerated Phase Chronic Myeloid LeukemiaBlast Phase Chronic Myeloid Leukemia+6 more
Incyte Biosciences International Sàrl 70
Testing effectiveness (Phase 2)Study completedNCT00005618
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00019656
What this trial is testing

Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00015951
What this trial is testing

Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers

Who this might be right for
LeukemiaMyelodysplastic Syndromes
University of Maryland, Baltimore
Testing effectiveness (Phase 2)Study completedNCT00042003
What this trial is testing

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

Who this might be right for
Chronic Myelogenous Leukemia
Astex Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT01279473
What this trial is testing

Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia
Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Ended earlyNCT00276159
What this trial is testing

Study of Immune Response Modifier in the Treatment of Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaNon-Hodgkin's Lymphoma+3 more
Masonic Cancer Center, University of Minnesota 6
Early research (Phase 1)UnknownNCT04272957
What this trial is testing

HMPL-306 in Patients With IDH1 and/or IDH2 Mutation of Relapsed/Refractory Myeloid Leukemia/Neoplasms

Who this might be right for
Acute Myeloid Leukemia
Hutchison Medipharma Limited 75
Early research (Phase 1)Study completedNCT02730312
What this trial is testing

PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaB-cell Acute Lymphoblastic LeukemiaBlastic Plasmacytoid Dendritic Cell Neoplasm+1 more
Xencor, Inc. 120
Not applicableActive Not RecruitingNCT06665412
What this trial is testing

Efficacy and Safety of Dose Redution of Radotinib as a First Line Treament in Ph+ CML

Who this might be right for
Chronic Phase Ph+ Chronic Myeloid Leukemia
Il-Yang Pharm. Co., Ltd. 169
Not applicableStudy completedNCT00920842
What this trial is testing

Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant

Who this might be right for
Cardiovascular ComplicationsLeukemiaLong-term Effects Secondary to Cancer Therapy in Children+1 more
Fred Hutchinson Cancer Center 244
Testing effectiveness (Phase 2)Study completedNCT01602952
What this trial is testing

Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myelogenous, Chronic, BCR-ABL Positive+2 more
Il-Yang Pharm. Co., Ltd. 85
Testing effectiveness (Phase 2)Study completedNCT00462943
What this trial is testing

Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML

Who this might be right for
Chronic Myeloid Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 100
Testing effectiveness (Phase 2)Study completedNCT03047993
What this trial is testing

Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia With Multilineage DysplasiaBlasts 20-30 Percent of Bone Marrow Nucleated CellsBlasts 20-30 Percent of Peripheral Blood White Cells+4 more
M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT00112567
What this trial is testing

Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Active Not RecruitingNCT02530034
What this trial is testing

Hu8F4 in Treating Patients With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveHematopoietic and Lymphoid Cell Neoplasm+8 more
M.D. Anderson Cancer Center 72
Testing effectiveness (Phase 2)Study completedNCT00136409
What this trial is testing

Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML)

Who this might be right for
MyelofibrosisMyeloid MetaplasiaAgnogenic Myeloid Metaplasia+1 more
Dana-Farber Cancer Institute 34
Next Page